Subjects aged @-@ years ( n = @ ) and @-@ years ( n = @ ) were randomized to receive two primary doses of A/H@N@ vaccine containing either @ g antigen with half a standard dose of MF@ adjuvant , @ g antigen with a full dose of MF@ , or ( children @-@ years only ) , a non-adjuvanted @ g formulation .